<?xml version="1.0" encoding="UTF-8"?>
<p id="p0165">Safety was assessed in the safety analysis set, which included all patients who received at least one dose of JR-141. The number andÂ proportion of subjects who experienced any adverse drug reactions were recorded, along with the total number of adverse drug reactions. For all adverse events, the verbatim terms used in the case report forms were coded according to the System Organ Class and Preferred Term specified in the Medical Dictionary for Regulatory Activities version 20.1 (developed by the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use).</p>
